However, AD mice treated with Duolac ATP showed a decrease in Th2 and Th17, with a concurrent increase in IL-2 (Figure 5D) and IFN-gamma (Figure 5E and Supplementary Figure S6A). The gene discussed is IFNG; the disease is Alzheimer disease.